Macquarie Group’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,460
| Closed | -$4.05K | – | 1855 |
|
|
2024
Q2 | $4.05K | Buy |
+3,460
| New | +$4.05K | ﹤0.01% | 1740 |
|
|
2019
Q1 | – | Sell |
-2,910
| Closed | -$9K | – | 1946 |
|
|
2018
Q4 | $9K | Sell |
2,910
-7,064
| -71% | -$21.8K | ﹤0.01% | 1945 |
|
|
2018
Q3 | $73K | Sell |
9,974
-6,028
| -38% | -$44.1K | ﹤0.01% | 1656 |
|
|
2018
Q2 | $69K | Buy |
16,002
+11,872
| +287% | +$51.2K | ﹤0.01% | 1908 |
|
|
2018
Q1 | $22K | Sell |
4,130
-7,250
| -64% | -$38.6K | ﹤0.01% | 2073 |
|
|
2017
Q4 | $75K | Buy |
+11,380
| New | +$75K | ﹤0.01% | 1945 |
|